Open Clinical Trials for Head and Neck Cancer

Head and Neck Cancer Studies Currently Recruiting Participants at SimmonsCooper Cancer Research Center at Southern Illinois University

Protocol Title	Study #	Study Group
Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and for Non-Adenoid Cystic Malignant Salivary Tumors	09-029	SCCI
A Phase II Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)	05-142	SCCI
An Open Label Single Arm Trial Investigating Zalatumumab, a Human Monoclonal Anti-EGF R Antibody, in Combination With Best Supportive Care, in Patients With Non-Curable Squamous Cell Carcinoma of the Head and Neck Who Have Failed Standard Platinum Based Chemotherapy	08-004	SCCI
A Randomized, Double-Blind, Placebo-Controlled, Multi-centre, Phase III Study of Post-Operative Adjuvant Lapatinib or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib or Placebo Monotherapy in High-Risk Subjects with Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)	08-095	SCCI/ RTOG
Resistance Training and Physical Functioning in Head and Neck Cancer Patients (RETAIN)	RETAIN	SIU IM
Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy	COG ARAR0331	SIU COG
A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab In Patients With Recurrent Or Metastatic Head and Neck Cancer	ECOG E1305	CICCOP
A Randomized Phase II Trial of Chemoradiotherapy Versus Chemoradiotherapy and Vandetanib for High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck	RTOG 0619	RTOG
Cancer Care/Symptom Management
A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment	SWOG S0702	SCCI

Although our objective is to provide an updated listing of available clinical trials please note that a listing here does not guarantee that a trial is open or available to any specific patient and that there may be additional trials available that are not listed. Complete information is only available from a treating physician.

Contact Information:

SimmonsCooper Cancer Institute Clinical Trials Office
Mail Code 9677 Fax (217) 545-6823

Kathy Robinson, PhD, Director of Clinical Trials
(217) 545-1946

Susan Klug, RN, OCN
(217) 545-7929

Jennifer Bekker RN, BSN
(217) 545-2219

SIU COG

Carol Peterson, RN, CCRP (217) 545-7377

SIU IM

Amanda Fogleman, B.A. (217) 545-0592

Cathy Naritoku, M.S., RD (217)545-8078

SIU Thoracic